Central Drugs Standard Control Organisation has approved phase II trials of Bharat Biotech's vaccine candidate Covaxin. After satisfactory results of Phase I clinical trial, DCGI has given permission for phase II trials of Covaxin, which is developed by Bharat biotech in alliance with the ICMR - National Institute of Virology.
source https://www.pharmatutor.org/pharma-news/2020/covaxin-got-dcgi-nod-for-phase-ii-clinical-trial
No comments:
Post a Comment